Description

Corinfar (nifedipine) retard tablets with prolonged release 20 mg. №50 vial

Ingredients

Active ingredient: Nifedipine 20 mg.
Other ingredients: lactose monohydrate, cellulose microcrystalline, colloidal anhydrous silica, magnesium stearate.

Dosage

Adults: The usual dose is one tablet every 12 hours. The dosage may vary depending on the individual’s condition and response to treatment. Consult a healthcare professional for personalized recommendations.

Indications

Corinfar (nifedipine) retard tablets are indicated for the treatment of hypertension (high blood pressure) and angina pectoris (chest pain).

Contraindications

Do not use Corinfar (nifedipine) retard tablets if:

• You are allergic to nifedipine or any other ingredients in the product.
• You have severe hypotension (low blood pressure).
• You are pregnant or breastfeeding without medical advice.

Directions

Take Corinfar (nifedipine) retard tablets with prolonged release 20 mg as directed by your healthcare provider. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence

Nifedipine, the active ingredient in Corinfar retard tablets, is a calcium channel blocker that works by relaxing blood vessels, thereby improving blood flow and reducing blood pressure. Studies have shown the efficacy of nifedipine in the management of hypertension and angina. Research published in the Journal of Hypertension demonstrated the long-term benefits of nifedipine in reducing cardiovascular events in patients with hypertension.

Additional Information

It is important to follow the prescribed dosage and not exceed the recommended amount to avoid adverse effects. Inform your healthcare provider about any other medications or supplements you are taking to prevent interactions. Regular monitoring of blood pressure and heart function is essential during treatment with Corinfar (nifedipine) retard tablets.

Corinfar (nifedipine) retard tablets with prolonged release 20 mg provide a convenient and effective treatment option for individuals with hypertension and angina. By maintaining consistent levels of nifedipine in the body, these tablets help in controlling blood pressure and reducing the frequency of angina episodes. Clinical trials have shown the sustained efficacy of nifedipine in managing these conditions, making it a trusted choice among healthcare professionals.

The pharmacological action of nifedipine involves blocking calcium channels in vascular smooth muscle, leading to vasodilation and decreased peripheral resistance. This mechanism results in improved oxygen delivery to the heart and reduced workload on the heart muscle, contributing to the management of angina and hypertension. Compared to other calcium channel blockers, nifedipine’s prolonged-release formulation offers a more consistent and sustained effect, enhancing patient compliance and treatment outcomes.